CT Quantification of Effects of Thalidomide in Patients with Metastatic Renal Cell Carcinoma

200733 citationsJournal Articlegreen Open Access

Authors

Silvana C. Faria · The University of Texas MD Anderson Cancer Center

Chaan S. Ng · The University of Texas MD Anderson Cancer Center

Kenneth R. Hess · The University of Texas MD Anderson Cancer Center

Sith Phongkitkarun · The University of Texas MD Anderson Cancer Center

Jacob Szejnfeld

Danai Daliani · The University of Texas MD Anderson Cancer Center

Chusilp Charnsangavej ·

Abstract

Changes in functional CT parameters 12 weeks after treatment may be useful for monitoring the effects of thalidomide and predicting treatment outcome among patients with metastatic renal cell carcinoma. Further study with a larger clinical trial is needed.

Topics & Keywords

Renal cell carcinoma treatment Radiomics and Machine Learning in Medical Imaging MRI in cancer diagnosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Roentgenology

Volume 189, Issue 2, pp. 378-385

DOI: 10.2214/ajr.07.2164

Field-Weighted Citation Impact: 2.61